Next Article in Journal
Immunoassay for Natamycin Trace Screening: Bread, Wine and Other Edibles Analysis
Next Article in Special Issue
An Experimental Framework for Developing Point-of-Need Biosensors: Connecting Bio-Layer Interferometry and Electrochemical Impedance Spectroscopy
Previous Article in Journal
Machine Learning-Enabled Prediction of 3D-Printed Microneedle Features
Previous Article in Special Issue
Context-Aware Diagnostic Specificity (CADS)
 
 
Review
Peer-Review Record

Progression of LAMP as a Result of the COVID-19 Pandemic: Is PCR Finally Rivaled?

Biosensors 2022, 12(7), 492; https://doi.org/10.3390/bios12070492
by Cassidy Mannier and Jeong-Yeol Yoon *
Reviewer 1:
Reviewer 2: Anonymous
Reviewer 3:
Biosensors 2022, 12(7), 492; https://doi.org/10.3390/bios12070492
Submission received: 21 May 2022 / Revised: 1 July 2022 / Accepted: 2 July 2022 / Published: 6 July 2022
(This article belongs to the Special Issue Detection of Proteins for Context-Aware Diagnostics)

Round 1

Reviewer 1 Report

1.      I would suggest including better resolution images for figures 3-7, if possible.

2.      As shown in Table 1, the sensitivity of the LAMP reaction is described, and related descriptions are also given below the table, in which a comparison with PCR is mentioned. If possible, it is suggested to add a relevant comparison between the existing LAMP and PCR methods of the Convid-19 detection, which can be presented in table form. 

3.      In section 3.4, the author have a brief review of the all-in-one LAMP system, However, the all-in-one system based on microfluidic technology (such as the digital microfluidic system) in the current study has also been widely applied in the detection of COVID-19 based on LAMP method, and has shown obvious advantages. It is suggested that the author add relevant brief discussion to the review. 

 

4.      In figure 3, such as figure C also include the original figure number B), and figure D also can see the original name fig 1 and fig 2. The original name will make a misunderstanding of the figure, if possible, please revised it.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The reviewed manuscript is decicated to LAMP in the aspect of COVID-19 pandemic. Authors described the state of affairs in the application and development of new LAMP-based tests for SARS-CoV-2 testing. The review is timely and provides an interesting survey for researchers in the field of molecular diagnostics. However, a few comments need to be made concerning several issues:

1.       Page 1 lanes 35-36 “Since most viruses are RNA viruses, including SARS-CoV-2, RNA must be converted to complementary DNA” – it would be better to reformulate that statement as RNA viruses are not the most prevalent for all domains of life.

2.       Page 1 lanes 43 “while PCR typically requires three temperatures” – commonly using TaqMan-based PCR tests are based on cycling of 2 temperatures.

3.       Page 2, lane 73 “LAMP is far more prone to “false positives.”” – while LAMP is prone to false positive results, it also have several other limitations, e.g. the need for conservative sites for 4-6 primers whisch is tricky for highly diverse viruses.

4.       Page 4, lane 127 “In terms of point-of-care diagnostics, LAMP holds the most potential for portability” – other methods of isothermal amplification also could be use for lab-on-chip devices.

5.       Page 6, lane 202 “Numerous fluorescent microplate readers and even real-time LightCyclers originally” – it would be better to change “LightCyclers” to “PCR machines”.

6.       Tables with specs of various LAMP-based devices would improve the readability of the manuscript.

7.       A paragraph describing various approaches for the detection of LAMP results would be highly appreciated.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 3 Report

See the file

Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 3 Report

The authors improved the article a lot. However, I would still suggest some minor to major revisions on the resubmitted article.

Introduction:
* "and cost of the RT-PCR test -" (add the -)

* 'at the peak... some areas' --> RT-PCR has a relative long assay time as is stated in the previous sentence, but the time-toresult being up to two weeks is caused by other things. Elaborate on this.

* 'two to three' and 'four to six' (remove the -'s)

* combined with simple visual detection methods (instead of paired)

* 'proven to increase LAMP specificity and sensitivity' --> clinical or analytical sensitivity in this case?

Section 2

* Fraction of cases detected is not (exactly) the same as the clinical sensitivity. Please clarify/adjust.

Section 3

* Split figure 3 in multiple figures. The subfigures are too small to be read properly.

* When multiple sentences after each other have the same reference, the reference can be put there once (at the end of the last sentence).

* SYBR Green is only inhibitory when the concentration is too high.

* What is the drawback of colorimetric detection? What about the sensitivity compared to other methods?

Later on in the article the sensitivy is discussed, which is good. But I miss an "introduction" sentence which explains what is going to be discussed in this section.

* Also figure 4 is quite crowded. Only keep the parts of the subfigures that are of interest. Also refer to the subfigures in the text.

* Figure 5: Again a very crowded picture; the steps are not readable. Please adapt the figure.

* There are multiple sources that state that the ID NOW makes use of the NEAR technique.

- https://pubs.rsc.org/en/content/articlelanding/2021/AY/D1AY00947H

- https://www.cell.com/iscience/fulltext/S2589-0042(20)30596-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589004220305964%3Fshowall%3Dtrue

- https://www.sciencedirect.com/science/article/pii/S259013702200053X

* Table 2 is a nice addition

* Figure 6 is also too crowded. Please adapt.

Section 4:

* 'RT-PCR yelds a decent overall clinical sensitivity' --> for which test? or mention according to whom. The statement as it is now is too bold. Also rephrase 'LAMP... yielded a clinical sensitivity of 65%'

Section 5:

* Some headers are still quite long. Only conclusion would be fine by me.

* Why are antigen tests unreliable?

* Do not introduce new information in the conclusion (e.g. the work of Pu et al.)

* What is meant with 'false rate'. More information is needed to place the 6-12% rate. In comparison to what for instance? Which tests?

 

 

 

 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 3

Reviewer 3 Report

* check the sentence: has also been proven to increase LAMP
analytical specificity and sensitivity and specificity [33] and clinical specificity and sensitivity [34-35].

* pictures are still quite crowded

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop